Projects and Grants per year
Personal profile
Research Interests
- Ovarian Cancer Screening.
- Chemotherapy Induced Cognitive Impairment.
- Developmental therapeutics in gynecologic cancer.
- Implementation of Precision Medicine.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Residency, Dartmouth College
2006
Doctor of Medicine, University Of Kentucky
2003
Bachelor of Science, University Of Kentucky
1998
Fingerprint
Dive into the research topics where Rachel Miller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
CCSG Pilot: Partnering to Impact Testing in the Commonwealth for Hereditary Cancers - PITCH
Miller, R. (PI), Keys, T. (CoI), Pickarski, J. (CoI), Yan, D. (CoI) & Zhang, S. (CoI)
8/1/24 → 6/30/26
Project: Research project
-
GOG-3091: A Two-Arm Randomized, Double-Blind, Placebo-Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination with Atezolizumab in Patients with HPV16-Positive, PD-L1-positive, Recurrent or Metastatic Cerv
Miller, R. (PI)
Gynecological Oncology Group Foundation Incorporated
5/14/24 → 5/14/26
Project: Research project
-
IMGN853-0421/GOG-3078: Randomized, Multicenter, Open-label, Phase 3 study of Mirvetuximab Soravtansine in Combination with Bevacizumab Versus Bevacizumab Alone as Maintenance Therapy for Patients with FRa-positive Recurrent Platinum-sensitive Epithelial o
Miller, R. (PI)
8/30/23 → 8/30/26
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-Paclitaxel Versus Placebo Plus Carboplatin-Paclitaxel in Patients with Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Miller, R. (PI)
Gynecological Oncology Group Foundation Incorporated
11/15/19 → 1/16/27
Project: Research project
-
Member Institution Purchased Service Agreement
Miller, R. (PI) & Romond, E. (Former PI)
NRG Oncology Foundation Incorporated
3/1/14 → 2/28/26
Project: Research project
-
Cisplatin-Containing Combinations Associate with Survival in Women from Appalachian Kentucky with Metastatic, Persistent, or Recurrent Uterine Cervix Cancer
Kunos, C. A., Miller, R. W. & Fabian, D., Oct 2024, In: Cancers. 16, 19, 3319.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports
Rives, T. A., Collard, J., Li, N., Yan, D., Dietrich, C. S., Miller, R. W., Ueland, F. R., Pickarski, J. & Kolesar, J. M., Sep 1 2024, In: JCO Precision Oncology. 8, e00301.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study
Hutchcraft, M. L., Zhang, S., Lin, N., Pickarski, J. C., Belcher, E. A., Wei, S., Bocklage, T., Miller, R. W., Villano, J. L., Cavnar, M. J., Kim, J., Arnold, S. M., Ueland, F. R. & Kolesar, J. M., Jan 1 2024, In: JCO Precision Oncology. 8, e2300266.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A phase i study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers
Gonzalez-Ochoa, E., Milosevic, M., Corr, B., Abbruzzese, J. L., Girda, E., Miller, R. W., Croke, J., Mackay, H., Lee, Y. C., Bowering, V., Ramsahai, J., Wang, L., D'Souza, A., Kunos, C. A., Oza, A. M. & Lheureux, S., Aug 1 2023, In: International Journal of Gynecological Cancer. 33, 8, p. 1208-1214 7 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Hemoglobin level associates with survival in women from Appalachian Kentucky with uterine cervix cancer
Kunos, C. A., Fabian, D., Fredericks, T., Baldwin, L., Dietrich, C., Miller, R. W. & Ueland, F. R., 2023, In: Frontiers in Oncology. 13, 1132135.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations